LABIANA HEALTH S.A.EO-10 Cash Flow Reinvestment Rate

Latest as of December 2025: 2.73x

LABIANA HEALTH S.A.EO-10 cash flow reinvestment rate. LABIANA HEALTH S.A.EO-10 (8RK) has a Cash Flow Reinvestment Rate of 2.73x as of December 2025, reinvesting €4.63 Million (capex €4.44 Million plus investments €196.45K) from operating cash flow of €1.70 Million. See 8RK financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

2.73x
(Capex + Investments) / Operating CF

Total Reinvested

€4.63 Million
Capex + Investments

Operating Cash Flow

€1.70 Million
EUR

Capital Expenditures

€4.44 Million
EUR

Cash Flow Reinvestment Rate of LABIANA HEALTH S.A.EO-10 (2021–2025)

Cash flow reinvestment rate of LABIANA HEALTH S.A.EO-10 from 2021 to 2025. Historical reinvestment intensity for LABIANA HEALTH S.A.EO-10 across 4 annual periods. Explore debt repayment capacity of LABIANA HEALTH S.A.EO-10 to assess how comfortably operating cash covers total debt obligations.

LABIANA HEALTH S.A.EO-10 Cash Flow Reinvestment Rate by Year (2021–2025)

LABIANA HEALTH S.A.EO-10 cash flow reinvestment rate by year from 2021 to 2025. Year-by-year capital reinvestment analysis for LABIANA HEALTH S.A.EO-10. For the full cash flow conversion analysis, see LABIANA HEALTH S.A.EO-10 (8RK) cash conversion ratio.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 2.73x €4.63 Million €1.70 Million €4.44 Million ▲ +396.4%
2024 0.55x €3.95 Million €7.19 Million €3.05 Million ▼ -67.7%
2022 1.70x €7.96 Million €4.68 Million €5.45 Million ▼ -21.7%
2021 2.17x €8.49 Million €3.91 Million €4.77 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow